Healthcare Global Enterprises Limited (HCG), a leading provider of specialized oncology services in India, has announced its unaudited financial results for the quarter and six months ended September 30, 2025, along with key corporate actions.

Financial Performance

For the quarter ended September 30, 2025, HCG reported:

The company's consolidated revenue from operations for Q2 FY2026 stood at ₹64,516 lakhs, marking a 16.8% increase from the corresponding quarter of the previous year. However, profit before tax decreased by 28.3% to ₹1,982 lakhs, while profit after tax remained relatively stable at ₹2,066 lakhs.

Employee Stock Option Allotment

The Board of Directors approved the issue and allotment of 7,537 equity shares of ₹10 each upon exercise of Employee Stock Options under the Employee Stock Option Scheme, 2021.

Board Meeting Details

The Board meeting, held on November 12, 2025, commenced at 10:30 a.m. and concluded at 5:30 p.m. During this meeting, the Board considered and approved the unaudited financial results for both standalone and consolidated operations.

Auditor's Review

BSR & Co. LLP, the statutory auditors, conducted a limited review of the financial results and issued an unmodified opinion. The review report notes that the acquisition of the oncology hospital business from HCG NCHRI Oncology LLP, completed in the previous financial year, has been accounted for in accordance with the requirements of Appendix C to Ind AS 103.

Strategic Investments

The Board has approved an investment of up to ₹700 lakhs (in equivalent USD) in equity shares of Cancer Care Kenya Limited, a step-down subsidiary of the company. This investment is subject to applicable regulatory approvals and is based on the fair value determined by an independent valuer.

Market Impact

While the company has shown strong revenue growth, the decrease in profit before tax may raise questions among investors about operational efficiency and cost management. The investment in the Kenyan subsidiary signals HCG's continued focus on international expansion in the oncology care sector.

HCG's commitment to employee ownership through the ESOP allotment may be viewed positively by the market as a strategy to align employee interests with company performance.

Multiple schemes of Motilal Oswal Mutual Fund have recently increased their collective stake in Healthcare Global Enterprises Ltd, a move that pushes their total shareholding above the 5% mark. This acquisition, completed on October 29, 2025, has been reported under SEBI substantial acquisition regulations.

Acquisition Details

The mutual fund schemes acquired an additional 1,54,556 shares of Healthcare Global Enterprises through market transactions. This strategic move has resulted in an increase in their collective holding from 4.93% to 5.04% of the company's total share capital.

Transaction Specifics

• Date of Acquisition: October 29, 2025
• Mode of Acquisition: Market Transactions
• Total Equity Share Capital: 14,10,00,100 shares (Face value of Rs. 10 each)

Participating Schemes

The acquisition was carried out by multiple schemes of Motilal Oswal Mutual Fund, including:

1. Motilal Oswal Balanced Advantage Fund
2. Motilal Oswal S And P BSE Healthcare ETF
3. Motilal Oswal Nifty Microcap 250 Index Fund
4. Motilal Oswal Multi Cap Fund
5. Motilal Oswal Business Cycle Fund
6. Motilal Oswal Infrastructure Fund
7. Motilal Oswal Active Momentum Fund
8. Motilal Oswal Special Opportunities Fund
9. Motilal Oswal BSE 1000 Index Fund
10. Motilal Oswal Services Fund
11. Motilal Oswal Consumption Fund

Regulatory Compliance

The transaction has been reported in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Motilal Oswal Asset Management Company Limited, as the investment manager to Motilal Oswal Mutual Fund, has duly informed the stock exchanges about this acquisition.

This move by Motilal Oswal Mutual Fund indicates their investment decision regarding Healthcare Global Enterprises, a company listed on both the BSE Limited and the National Stock Exchange of India Limited.